We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

88 hedge funds and large institutions have $228M invested in ChemoCentryx, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

32% more capital invested

Capital invested by funds: $173M → $228M (+$55.4M)

5% more funds holding

Funds holding: 84 → 88 (+4)

7% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 29

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $103K

Holders
88
Holders Change
+4
Holders Change %
+4.76%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
31
Reduced
29
Closed
7
Calls
–
Puts
$103K
Net Calls
-$103K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.89M
2
WA
Wasatch Advisors
Utah
+$1.54M
3
BlackRock
BlackRock
New York
+$1.28M
4
Renaissance Technologies
Renaissance Technologies
New York
+$782K
5
BTS
BB&T Securities
Virginia
+$613K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$986K
2
CFIC
City Financial Investment Company
United Kingdom
-$566K
3
Franklin Resources
Franklin Resources
California
-$541K
4
Bank of America
Bank of America
North Carolina
-$494K
5
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$369K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$77.2M +$1.89M +257,844 +3%
BlackRock
2
BlackRock
New York
$21.8M +$1.28M +174,471 +8%
WA
3
Wasatch Advisors
Utah
$21.1M +$1.54M +210,039 +10%
Franklin Resources
4
Franklin Resources
California
$19.3M -$541K -73,700 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.3M +$98K +13,344 +1%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$8.29M +$233K +31,724 +4%
Renaissance Technologies
7
Renaissance Technologies
New York
$6.77M +$782K +106,570 +17%
NCM
8
Nantahala Capital Management
Connecticut
$5.67M – – –
AG
9
Artal Group
Luxembourg
$4.68M -$340K -46,278 -8%
State Street
10
State Street
Massachusetts
$4.02M +$205K +27,896 +7%
Northern Trust
11
Northern Trust
Illinois
$2.59M +$177K +24,134 +10%
Deutsche Bank
12
Deutsche Bank
Germany
$2.53M +$542K +73,820 +38%
IHM
13
Iguana Healthcare Management
New York
$2.34M – – –
SCM
14
Sio Capital Management
New York
$2.29M -$362K -49,300 -17%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$2.26M -$163K -22,257 -8%
PAM
16
Panagora Asset Management
Massachusetts
$1.92M +$375K +51,100 +33%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.88M +$27.6K +3,762 +2%
OAM
18
Oxford Asset Management
United Kingdom
$1.68M -$266K -36,222 -17%
PAWC
19
P.A.W. Capital
Connecticut
$1.5M – – –
AllianceBernstein
20
AllianceBernstein
Tennessee
$1.5M -$150K -20,400 -11%
SIM
21
Spark Investment Management
New York
$1.18M -$134K -18,200 -13%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$1.18M +$221K +30,099 +31%
Millennium Management
23
Millennium Management
New York
$1.13M -$238K -32,369 -21%
EC
24
EcoR1 Capital
California
$1.1M – – –
Russell Investments Group
25
Russell Investments Group
United Kingdom
$1.09M +$161K +21,922 +23%
1
2 3 4

CCXI Hedge Fund Activity: Q2 2017 in Review

88 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2017, worth a combined $228M — up 32% from $173M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 7 closed out — a net gain of 4 holders — while 31 added to existing stakes and 29 trimmed.

The largest buyer was BVF Inc, adding an estimated $1.89M. The largest seller was Invesco, cutting an estimated $986K.

  • 88 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2017, up from 84 in Q1 2017.
  • Funds reported $228M of ChemoCentryx, Inc. stock for Q2 2017, up 32% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q2 2017 and 7 closed out, a net change of +4 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2017 was BVF Inc, an estimated $1.89M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2017 was Invesco, an estimated $986K sold.

Based on aggregated 13F filings for Q2 2017.